nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylnaltrexone—CYP2D6—Ciclesonide—asthma	0.0973	0.17	CbGbCtD
Methylnaltrexone—CYP2D6—Ipratropium bromide—asthma	0.0807	0.141	CbGbCtD
Methylnaltrexone—CYP2D6—Zafirlukast—asthma	0.071	0.124	CbGbCtD
Methylnaltrexone—CYP2D6—Arformoterol—asthma	0.0686	0.12	CbGbCtD
Methylnaltrexone—CYP2D6—Formoterol—asthma	0.0686	0.12	CbGbCtD
Methylnaltrexone—CYP2D6—Tiotropium—asthma	0.0611	0.107	CbGbCtD
Methylnaltrexone—CYP2D6—Theophylline—asthma	0.0548	0.0958	CbGbCtD
Methylnaltrexone—CYP2D6—Loratadine—asthma	0.052	0.0909	CbGbCtD
Methylnaltrexone—CYP2D6—Dexamethasone—asthma	0.018	0.0314	CbGbCtD
Methylnaltrexone—Naloxone—TLR4—asthma	0.0035	0.889	CrCbGaD
Methylnaltrexone—Dizziness—Indacaterol—asthma	0.00105	0.0041	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Fluticasone Propionate—asthma	0.00105	0.0041	CcSEcCtD
Methylnaltrexone—Diarrhoea—Pirbuterol—asthma	0.00105	0.0041	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Salmeterol—asthma	0.00104	0.00409	CcSEcCtD
Methylnaltrexone—Oedema—Ipratropium bromide—asthma	0.00104	0.00409	CcSEcCtD
Methylnaltrexone—Dizziness—Orciprenaline—asthma	0.00104	0.00407	CcSEcCtD
Methylnaltrexone—Abdominal pain—Theophylline—asthma	0.00104	0.00407	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Ipratropium bromide—asthma	0.00102	0.00401	CcSEcCtD
Methylnaltrexone—Vomiting—Zileuton—asthma	0.00102	0.00401	CcSEcCtD
Methylnaltrexone—Dizziness—Nedocromil—asthma	0.00102	0.00399	CcSEcCtD
Methylnaltrexone—Skin disorder—Ipratropium bromide—asthma	0.00101	0.00397	CcSEcCtD
Methylnaltrexone—Dizziness—Pirbuterol—asthma	0.00101	0.00396	CcSEcCtD
Methylnaltrexone—Oedema—Fluticasone Propionate—asthma	0.00101	0.00396	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Ipratropium bromide—asthma	0.00101	0.00396	CcSEcCtD
Methylnaltrexone—Oedema—Salmeterol—asthma	0.00101	0.00395	CcSEcCtD
Methylnaltrexone—Diarrhoea—Fluticasone furoate—asthma	0.00101	0.00394	CcSEcCtD
Methylnaltrexone—Vomiting—Orciprenaline—asthma	0.000999	0.00392	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Fluticasone Propionate—asthma	0.000991	0.00388	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Salmeterol—asthma	0.000988	0.00387	CcSEcCtD
Methylnaltrexone—Nausea—Ketotifen—asthma	0.000986	0.00386	CcSEcCtD
Methylnaltrexone—Skin disorder—Fluticasone Propionate—asthma	0.000981	0.00385	CcSEcCtD
Methylnaltrexone—Skin disorder—Salmeterol—asthma	0.000979	0.00384	CcSEcCtD
Methylnaltrexone—Vomiting—Nedocromil—asthma	0.000978	0.00384	CcSEcCtD
Methylnaltrexone—Pain—Cromoglicic acid—asthma	0.000977	0.00383	CcSEcCtD
Methylnaltrexone—Dizziness—Fluticasone furoate—asthma	0.000972	0.00381	CcSEcCtD
Methylnaltrexone—Vomiting—Pirbuterol—asthma	0.000972	0.00381	CcSEcCtD
Methylnaltrexone—Nausea—Zileuton—asthma	0.000955	0.00374	CcSEcCtD
Methylnaltrexone—Diarrhoea—Zafirlukast—asthma	0.000945	0.0037	CcSEcCtD
Methylnaltrexone—Nausea—Indacaterol—asthma	0.00094	0.00369	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Aminophylline—asthma	0.000939	0.00368	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Loratadine—asthma	0.000937	0.00367	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—asthma	0.000935	0.00367	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Cromoglicic acid—asthma	0.000935	0.00366	CcSEcCtD
Methylnaltrexone—Nausea—Orciprenaline—asthma	0.000934	0.00366	CcSEcCtD
Methylnaltrexone—Nausea—Nedocromil—asthma	0.000914	0.00358	CcSEcCtD
Methylnaltrexone—Dizziness—Zafirlukast—asthma	0.000913	0.00358	CcSEcCtD
Methylnaltrexone—Nausea—Pirbuterol—asthma	0.000908	0.00356	CcSEcCtD
Methylnaltrexone—Abdominal pain—Cromoglicic acid—asthma	0.000903	0.00354	CcSEcCtD
Methylnaltrexone—Oedema—Tiotropium—asthma	0.000903	0.00354	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Ipratropium bromide—asthma	0.000901	0.00353	CcSEcCtD
Methylnaltrexone—Diarrhoea—Theophylline—asthma	0.000899	0.00353	CcSEcCtD
Methylnaltrexone—Pain—Ipratropium bromide—asthma	0.000893	0.0035	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Loratadine—asthma	0.000887	0.00348	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Tiotropium—asthma	0.000885	0.00347	CcSEcCtD
Methylnaltrexone—Skin disorder—Loratadine—asthma	0.000878	0.00344	CcSEcCtD
Methylnaltrexone—Vomiting—Zafirlukast—asthma	0.000878	0.00344	CcSEcCtD
Methylnaltrexone—Skin disorder—Tiotropium—asthma	0.000877	0.00344	CcSEcCtD
Methylnaltrexone—Nausea—Fluticasone furoate—asthma	0.000873	0.00342	CcSEcCtD
Methylnaltrexone—Dizziness—Theophylline—asthma	0.000869	0.00341	CcSEcCtD
Methylnaltrexone—Dizziness—Beclomethasone—asthma	0.000869	0.00341	CcSEcCtD
Methylnaltrexone—Pain—Fluticasone Propionate—asthma	0.000864	0.00339	CcSEcCtD
Methylnaltrexone—Pain—Salmeterol—asthma	0.000862	0.00338	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Ipratropium bromide—asthma	0.000854	0.00335	CcSEcCtD
Methylnaltrexone—Oedema—Flunisolide—asthma	0.000837	0.00328	CcSEcCtD
Methylnaltrexone—Vomiting—Theophylline—asthma	0.000836	0.00328	CcSEcCtD
Methylnaltrexone—Dizziness—Ciclesonide—asthma	0.000832	0.00326	CcSEcCtD
Methylnaltrexone—Flatulence—Salbutamol—asthma	0.000831	0.00326	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Fluticasone Propionate—asthma	0.000826	0.00324	CcSEcCtD
Methylnaltrexone—Abdominal pain—Ipratropium bromide—asthma	0.000825	0.00323	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Salmeterol—asthma	0.000824	0.00323	CcSEcCtD
Methylnaltrexone—Nausea—Zafirlukast—asthma	0.00082	0.00322	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Flunisolide—asthma	0.000809	0.00317	CcSEcCtD
Methylnaltrexone—Flatulence—Budesonide—asthma	0.000804	0.00315	CcSEcCtD
Methylnaltrexone—Abdominal pain—Fluticasone Propionate—asthma	0.000799	0.00313	CcSEcCtD
Methylnaltrexone—Abdominal pain—Salmeterol—asthma	0.000797	0.00312	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Aminophylline—asthma	0.000783	0.00307	CcSEcCtD
Methylnaltrexone—Diarrhoea—Cromoglicic acid—asthma	0.000782	0.00307	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Loratadine—asthma	0.000781	0.00306	CcSEcCtD
Methylnaltrexone—Nausea—Theophylline—asthma	0.000781	0.00306	CcSEcCtD
Methylnaltrexone—Nausea—Beclomethasone—asthma	0.000781	0.00306	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Tiotropium—asthma	0.000779	0.00306	CcSEcCtD
Methylnaltrexone—Pain—Loratadine—asthma	0.000773	0.00303	CcSEcCtD
Methylnaltrexone—Abdominal pain—Aminophylline—asthma	0.000757	0.00297	CcSEcCtD
Methylnaltrexone—Dizziness—Cromoglicic acid—asthma	0.000756	0.00296	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Formoterol—asthma	0.000755	0.00296	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—asthma	0.000755	0.00296	CcSEcCtD
Methylnaltrexone—Nausea—Ciclesonide—asthma	0.000747	0.00293	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Loratadine—asthma	0.00074	0.0029	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Montelukast—asthma	0.000739	0.0029	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Tiotropium—asthma	0.000738	0.00289	CcSEcCtD
Methylnaltrexone—Oedema—Formoterol—asthma	0.000729	0.00286	CcSEcCtD
Methylnaltrexone—Oedema—Arformoterol—asthma	0.000729	0.00286	CcSEcCtD
Methylnaltrexone—Pain—Flunisolide—asthma	0.000715	0.0028	CcSEcCtD
Methylnaltrexone—Abdominal pain—Loratadine—asthma	0.000715	0.0028	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Arformoterol—asthma	0.000714	0.0028	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Formoterol—asthma	0.000714	0.0028	CcSEcCtD
Methylnaltrexone—Diarrhoea—Ipratropium bromide—asthma	0.000714	0.0028	CcSEcCtD
Methylnaltrexone—Abdominal pain—Tiotropium—asthma	0.000714	0.0028	CcSEcCtD
Methylnaltrexone—Oedema—Montelukast—asthma	0.000714	0.0028	CcSEcCtD
Methylnaltrexone—Skin disorder—Arformoterol—asthma	0.000708	0.00277	CcSEcCtD
Methylnaltrexone—Skin disorder—Formoterol—asthma	0.000708	0.00277	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Montelukast—asthma	0.0007	0.00274	CcSEcCtD
Methylnaltrexone—Skin disorder—Montelukast—asthma	0.000693	0.00272	CcSEcCtD
Methylnaltrexone—Diarrhoea—Fluticasone Propionate—asthma	0.000691	0.00271	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Budesonide—asthma	0.00069	0.00271	CcSEcCtD
Methylnaltrexone—Dizziness—Ipratropium bromide—asthma	0.00069	0.00271	CcSEcCtD
Methylnaltrexone—Diarrhoea—Salmeterol—asthma	0.00069	0.0027	CcSEcCtD
Methylnaltrexone—Oedema—Salbutamol—asthma	0.000688	0.0027	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Flunisolide—asthma	0.000684	0.00268	CcSEcCtD
Methylnaltrexone—Nausea—Cromoglicic acid—asthma	0.000679	0.00266	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Salbutamol—asthma	0.000675	0.00264	CcSEcCtD
Methylnaltrexone—Skin disorder—Salbutamol—asthma	0.000668	0.00262	CcSEcCtD
Methylnaltrexone—Dizziness—Fluticasone Propionate—asthma	0.000668	0.00262	CcSEcCtD
Methylnaltrexone—Dizziness—Salmeterol—asthma	0.000667	0.00261	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Salbutamol—asthma	0.000665	0.00261	CcSEcCtD
Methylnaltrexone—Vomiting—Ipratropium bromide—asthma	0.000664	0.0026	CcSEcCtD
Methylnaltrexone—Pain—Mometasone—asthma	0.000664	0.0026	CcSEcCtD
Methylnaltrexone—Abdominal pain—Flunisolide—asthma	0.000661	0.00259	CcSEcCtD
Methylnaltrexone—Diarrhoea—Aminophylline—asthma	0.000655	0.00257	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Budesonide—asthma	0.000653	0.00256	CcSEcCtD
Methylnaltrexone—Skin disorder—Budesonide—asthma	0.000647	0.00254	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Budesonide—asthma	0.000644	0.00253	CcSEcCtD
Methylnaltrexone—Vomiting—Fluticasone Propionate—asthma	0.000642	0.00252	CcSEcCtD
Methylnaltrexone—Vomiting—Salmeterol—asthma	0.000641	0.00251	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Mometasone—asthma	0.000635	0.00249	CcSEcCtD
Methylnaltrexone—Dizziness—Aminophylline—asthma	0.000633	0.00248	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Formoterol—asthma	0.000629	0.00247	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Arformoterol—asthma	0.000629	0.00247	CcSEcCtD
Methylnaltrexone—Pain—Arformoterol—asthma	0.000623	0.00244	CcSEcCtD
Methylnaltrexone—Pain—Formoterol—asthma	0.000623	0.00244	CcSEcCtD
Methylnaltrexone—Nausea—Ipratropium bromide—asthma	0.00062	0.00243	CcSEcCtD
Methylnaltrexone—Diarrhoea—Loratadine—asthma	0.000619	0.00243	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Montelukast—asthma	0.000616	0.00242	CcSEcCtD
Methylnaltrexone—Abdominal pain—Mometasone—asthma	0.000614	0.00241	CcSEcCtD
Methylnaltrexone—Pain—Montelukast—asthma	0.00061	0.00239	CcSEcCtD
Methylnaltrexone—Vomiting—Aminophylline—asthma	0.000609	0.00239	CcSEcCtD
Methylnaltrexone—Nausea—Fluticasone Propionate—asthma	0.0006	0.00235	CcSEcCtD
Methylnaltrexone—Nausea—Salmeterol—asthma	0.000599	0.00235	CcSEcCtD
Methylnaltrexone—Dizziness—Loratadine—asthma	0.000598	0.00234	CcSEcCtD
Methylnaltrexone—Dizziness—Tiotropium—asthma	0.000597	0.00234	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Arformoterol—asthma	0.000596	0.00234	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Formoterol—asthma	0.000596	0.00234	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Salbutamol—asthma	0.000594	0.00233	CcSEcCtD
Methylnaltrexone—Pain—Salbutamol—asthma	0.000588	0.00231	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Montelukast—asthma	0.000584	0.00229	CcSEcCtD
Methylnaltrexone—Abdominal pain—Arformoterol—asthma	0.000576	0.00226	CcSEcCtD
Methylnaltrexone—Abdominal pain—Formoterol—asthma	0.000576	0.00226	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Budesonide—asthma	0.000575	0.00226	CcSEcCtD
Methylnaltrexone—Vomiting—Loratadine—asthma	0.000575	0.00225	CcSEcCtD
Methylnaltrexone—Vomiting—Tiotropium—asthma	0.000574	0.00225	CcSEcCtD
Methylnaltrexone—Diarrhoea—Flunisolide—asthma	0.000572	0.00224	CcSEcCtD
Methylnaltrexone—Pain—Budesonide—asthma	0.00057	0.00223	CcSEcCtD
Methylnaltrexone—Nausea—Aminophylline—asthma	0.000569	0.00223	CcSEcCtD
Methylnaltrexone—Abdominal pain—Montelukast—asthma	0.000564	0.00221	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Salbutamol—asthma	0.000563	0.00221	CcSEcCtD
Methylnaltrexone—Dizziness—Flunisolide—asthma	0.000553	0.00217	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Budesonide—asthma	0.000545	0.00214	CcSEcCtD
Methylnaltrexone—Abdominal pain—Salbutamol—asthma	0.000544	0.00213	CcSEcCtD
Methylnaltrexone—Nausea—Loratadine—asthma	0.000537	0.00211	CcSEcCtD
Methylnaltrexone—Nausea—Tiotropium—asthma	0.000536	0.0021	CcSEcCtD
Methylnaltrexone—Vomiting—Flunisolide—asthma	0.000532	0.00209	CcSEcCtD
Methylnaltrexone—Diarrhoea—Mometasone—asthma	0.000531	0.00208	CcSEcCtD
Methylnaltrexone—Abdominal pain—Budesonide—asthma	0.000527	0.00206	CcSEcCtD
Methylnaltrexone—Diarrhoea—Formoterol—asthma	0.000498	0.00195	CcSEcCtD
Methylnaltrexone—Diarrhoea—Arformoterol—asthma	0.000498	0.00195	CcSEcCtD
Methylnaltrexone—Nausea—Flunisolide—asthma	0.000497	0.00195	CcSEcCtD
Methylnaltrexone—Vomiting—Mometasone—asthma	0.000493	0.00193	CcSEcCtD
Methylnaltrexone—Diarrhoea—Montelukast—asthma	0.000488	0.00191	CcSEcCtD
Methylnaltrexone—Erythema—Prednisolone—asthma	0.000483	0.0019	CcSEcCtD
Methylnaltrexone—Dizziness—Arformoterol—asthma	0.000482	0.00189	CcSEcCtD
Methylnaltrexone—Dizziness—Formoterol—asthma	0.000482	0.00189	CcSEcCtD
Methylnaltrexone—Erythema—Hydrocortisone—asthma	0.000472	0.00185	CcSEcCtD
Methylnaltrexone—Dizziness—Montelukast—asthma	0.000472	0.00185	CcSEcCtD
Methylnaltrexone—Diarrhoea—Salbutamol—asthma	0.000471	0.00185	CcSEcCtD
Methylnaltrexone—Vomiting—Formoterol—asthma	0.000463	0.00182	CcSEcCtD
Methylnaltrexone—Vomiting—Arformoterol—asthma	0.000463	0.00182	CcSEcCtD
Methylnaltrexone—Nausea—Mometasone—asthma	0.000461	0.00181	CcSEcCtD
Methylnaltrexone—Diarrhoea—Budesonide—asthma	0.000456	0.00179	CcSEcCtD
Methylnaltrexone—Dizziness—Salbutamol—asthma	0.000455	0.00178	CcSEcCtD
Methylnaltrexone—Vomiting—Montelukast—asthma	0.000454	0.00178	CcSEcCtD
Methylnaltrexone—Erythema—Triamcinolone—asthma	0.000445	0.00174	CcSEcCtD
Methylnaltrexone—Erythema—Methylprednisolone—asthma	0.000444	0.00174	CcSEcCtD
Methylnaltrexone—Dizziness—Budesonide—asthma	0.000441	0.00173	CcSEcCtD
Methylnaltrexone—Vomiting—Salbutamol—asthma	0.000437	0.00171	CcSEcCtD
Methylnaltrexone—Naloxone—ALB—asthma	0.000437	0.111	CrCbGaD
Methylnaltrexone—Nausea—Arformoterol—asthma	0.000433	0.0017	CcSEcCtD
Methylnaltrexone—Nausea—Formoterol—asthma	0.000433	0.0017	CcSEcCtD
Methylnaltrexone—Nausea—Montelukast—asthma	0.000424	0.00166	CcSEcCtD
Methylnaltrexone—Vomiting—Budesonide—asthma	0.000424	0.00166	CcSEcCtD
Methylnaltrexone—Nausea—Salbutamol—asthma	0.000409	0.0016	CcSEcCtD
Methylnaltrexone—Erythema—Dexamethasone—asthma	0.000403	0.00158	CcSEcCtD
Methylnaltrexone—Erythema—Betamethasone—asthma	0.000403	0.00158	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	0.000399	0.00156	CcSEcCtD
Methylnaltrexone—Nausea—Budesonide—asthma	0.000396	0.00155	CcSEcCtD
Methylnaltrexone—Oedema—Prednisolone—asthma	0.000395	0.00155	CcSEcCtD
Methylnaltrexone—Oedema—Hydrocortisone—asthma	0.000385	0.00151	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Prednisolone—asthma	0.000381	0.0015	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Hydrocortisone—asthma	0.000378	0.00148	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	0.000375	0.00147	CcSEcCtD
Methylnaltrexone—Skin disorder—Hydrocortisone—asthma	0.000374	0.00147	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Hydrocortisone—asthma	0.000373	0.00146	CcSEcCtD
Methylnaltrexone—Oedema—Triamcinolone—asthma	0.000363	0.00142	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Methylprednisolone—asthma	0.000355	0.00139	CcSEcCtD
Methylnaltrexone—Skin disorder—Methylprednisolone—asthma	0.000352	0.00138	CcSEcCtD
Methylnaltrexone—Erythema—Prednisone—asthma	0.000351	0.00138	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Triamcinolone—asthma	0.000351	0.00138	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Methylprednisolone—asthma	0.00035	0.00137	CcSEcCtD
Methylnaltrexone—Pain—Prednisolone—asthma	0.000337	0.00132	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Hydrocortisone—asthma	0.000333	0.0013	CcSEcCtD
Methylnaltrexone—Pain—Hydrocortisone—asthma	0.00033	0.00129	CcSEcCtD
Methylnaltrexone—Oedema—Betamethasone—asthma	0.000329	0.00129	CcSEcCtD
Methylnaltrexone—Oedema—Dexamethasone—asthma	0.000329	0.00129	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Dexamethasone—asthma	0.000323	0.00127	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Betamethasone—asthma	0.000323	0.00127	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Dexamethasone—asthma	0.000318	0.00125	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Betamethasone—asthma	0.000318	0.00125	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Hydrocortisone—asthma	0.000315	0.00124	CcSEcCtD
Methylnaltrexone—Pain—Triamcinolone—asthma	0.00031	0.00122	CcSEcCtD
Methylnaltrexone—Abdominal pain—Hydrocortisone—asthma	0.000305	0.00119	CcSEcCtD
Methylnaltrexone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	0.000297	0.00116	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Methylprednisolone—asthma	0.000296	0.00116	CcSEcCtD
Methylnaltrexone—Oedema—Prednisone—asthma	0.000287	0.00112	CcSEcCtD
Methylnaltrexone—Abdominal pain—Methylprednisolone—asthma	0.000286	0.00112	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Dexamethasone—asthma	0.000284	0.00111	CcSEcCtD
Methylnaltrexone—Gastrointestinal disorder—Betamethasone—asthma	0.000284	0.00111	CcSEcCtD
Methylnaltrexone—Pain—Dexamethasone—asthma	0.000282	0.0011	CcSEcCtD
Methylnaltrexone—Pain—Betamethasone—asthma	0.000282	0.0011	CcSEcCtD
Methylnaltrexone—Nervous system disorder—Prednisone—asthma	0.000281	0.0011	CcSEcCtD
Methylnaltrexone—Skin disorder—Prednisone—asthma	0.000278	0.00109	CcSEcCtD
Methylnaltrexone—Hyperhidrosis—Prednisone—asthma	0.000277	0.00109	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Dexamethasone—asthma	0.000269	0.00106	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Betamethasone—asthma	0.000269	0.00106	CcSEcCtD
Methylnaltrexone—Diarrhoea—Hydrocortisone—asthma	0.000264	0.00103	CcSEcCtD
Methylnaltrexone—Dizziness—Prednisolone—asthma	0.000261	0.00102	CcSEcCtD
Methylnaltrexone—Abdominal pain—Dexamethasone—asthma	0.00026	0.00102	CcSEcCtD
Methylnaltrexone—Abdominal pain—Betamethasone—asthma	0.00026	0.00102	CcSEcCtD
Methylnaltrexone—Dizziness—Hydrocortisone—asthma	0.000255	0.000999	CcSEcCtD
Methylnaltrexone—Diarrhoea—Methylprednisolone—asthma	0.000248	0.000971	CcSEcCtD
Methylnaltrexone—Vomiting—Hydrocortisone—asthma	0.000245	0.00096	CcSEcCtD
Methylnaltrexone—Dizziness—Triamcinolone—asthma	0.00024	0.000941	CcSEcCtD
Methylnaltrexone—Dizziness—Methylprednisolone—asthma	0.000239	0.000938	CcSEcCtD
Methylnaltrexone—Gastrointestinal pain—Prednisone—asthma	0.000234	0.000919	CcSEcCtD
Methylnaltrexone—Nausea—Prednisolone—asthma	0.000234	0.000919	CcSEcCtD
Methylnaltrexone—Vomiting—Triamcinolone—asthma	0.000231	0.000904	CcSEcCtD
Methylnaltrexone—Vomiting—Methylprednisolone—asthma	0.00023	0.000902	CcSEcCtD
Methylnaltrexone—Nausea—Hydrocortisone—asthma	0.000229	0.000897	CcSEcCtD
Methylnaltrexone—Abdominal pain—Prednisone—asthma	0.000227	0.000888	CcSEcCtD
Methylnaltrexone—Diarrhoea—Betamethasone—asthma	0.000225	0.000883	CcSEcCtD
Methylnaltrexone—Diarrhoea—Dexamethasone—asthma	0.000225	0.000883	CcSEcCtD
Methylnaltrexone—Dizziness—Betamethasone—asthma	0.000218	0.000853	CcSEcCtD
Methylnaltrexone—Dizziness—Dexamethasone—asthma	0.000218	0.000853	CcSEcCtD
Methylnaltrexone—Nausea—Triamcinolone—asthma	0.000216	0.000845	CcSEcCtD
Methylnaltrexone—Nausea—Methylprednisolone—asthma	0.000215	0.000843	CcSEcCtD
Methylnaltrexone—Vomiting—Dexamethasone—asthma	0.000209	0.000821	CcSEcCtD
Methylnaltrexone—Vomiting—Betamethasone—asthma	0.000209	0.000821	CcSEcCtD
Methylnaltrexone—Diarrhoea—Prednisone—asthma	0.000196	0.000769	CcSEcCtD
Methylnaltrexone—Nausea—Betamethasone—asthma	0.000196	0.000767	CcSEcCtD
Methylnaltrexone—Nausea—Dexamethasone—asthma	0.000196	0.000767	CcSEcCtD
Methylnaltrexone—Dizziness—Prednisone—asthma	0.00019	0.000743	CcSEcCtD
Methylnaltrexone—Vomiting—Prednisone—asthma	0.000182	0.000715	CcSEcCtD
Methylnaltrexone—Nausea—Prednisone—asthma	0.00017	0.000668	CcSEcCtD
Methylnaltrexone—OPRM1—Signaling Pathways—NPSR1—asthma	8.6e-05	0.000509	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PDE4A—asthma	8.53e-05	0.000505	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—KIF3A—asthma	8.53e-05	0.000505	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—KNG1—asthma	8.52e-05	0.000504	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—BDKRB2—asthma	8.51e-05	0.000504	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—AGTR1—asthma	8.47e-05	0.000501	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—AGTR2—asthma	8.46e-05	0.000501	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CSF2RB—asthma	8.42e-05	0.000498	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CXCL10—asthma	8.28e-05	0.00049	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TACR2—asthma	8.25e-05	0.000488	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCR8—asthma	8.25e-05	0.000488	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—ADCY2—asthma	8.23e-05	0.000487	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—IL5—asthma	8.21e-05	0.000486	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL3—asthma	8.2e-05	0.000486	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—EDNRB—asthma	8.1e-05	0.000479	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL17—asthma	8.09e-05	0.000479	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—ADRB2—asthma	8.04e-05	0.000476	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—NPS—asthma	8.02e-05	0.000474	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—TAC1—asthma	8.02e-05	0.000474	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CYSLTR1—asthma	7.98e-05	0.000473	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—BDKRB2—asthma	7.92e-05	0.000469	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CXCR3—asthma	7.86e-05	0.000465	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—KNG1—asthma	7.74e-05	0.000458	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CMA1—asthma	7.71e-05	0.000456	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCL11—asthma	7.71e-05	0.000456	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—UTS2—asthma	7.71e-05	0.000456	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—C5AR1—asthma	7.71e-05	0.000456	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—VIP—asthma	7.71e-05	0.000456	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—AGTR1—asthma	7.69e-05	0.000455	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—ADCY2—asthma	7.66e-05	0.000453	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—IL3—asthma	7.63e-05	0.000452	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	7.62e-05	0.000451	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—ITPR1—asthma	7.6e-05	0.00045	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CXCL10—asthma	7.52e-05	0.000445	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—POMC—asthma	7.51e-05	0.000444	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL5—asthma	7.45e-05	0.000441	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCR4—asthma	7.39e-05	0.000438	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCL2—asthma	7.34e-05	0.000435	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—ADRB2—asthma	7.3e-05	0.000432	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—STAT6—asthma	7.25e-05	0.000429	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PDE4A—asthma	7.21e-05	0.000427	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—KIF3A—asthma	7.21e-05	0.000427	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—KNG1—asthma	7.2e-05	0.000426	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—BDKRB2—asthma	7.19e-05	0.000426	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—EDN1—asthma	7.18e-05	0.000425	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—AGTR1—asthma	7.16e-05	0.000424	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCL5—asthma	7.13e-05	0.000422	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL2RB—asthma	7.12e-05	0.000421	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PDE4D—asthma	7.05e-05	0.000417	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—POMC—asthma	7.03e-05	0.000416	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CSF2—asthma	7.02e-05	0.000416	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CXCL10—asthma	7e-05	0.000414	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—ADCY2—asthma	6.96e-05	0.000412	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL3—asthma	6.93e-05	0.00041	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—ITPR1—asthma	6.9e-05	0.000409	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—C5—asthma	6.87e-05	0.000407	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PDE4B—asthma	6.87e-05	0.000407	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TACR1—asthma	6.87e-05	0.000407	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CXCL8—asthma	6.87e-05	0.000407	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—ADRB2—asthma	6.79e-05	0.000402	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CYSLTR1—asthma	6.75e-05	0.000399	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—LTC4S—asthma	6.63e-05	0.000393	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—KNG1—asthma	6.54e-05	0.000387	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—EDN1—asthma	6.52e-05	0.000386	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CMA1—asthma	6.52e-05	0.000386	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL11—asthma	6.52e-05	0.000386	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—UTS2—asthma	6.52e-05	0.000386	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—C5AR1—asthma	6.52e-05	0.000386	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—VIP—asthma	6.52e-05	0.000386	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—AGTR1—asthma	6.5e-05	0.000385	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCL5—asthma	6.47e-05	0.000383	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PLA2G4A—asthma	6.45e-05	0.000382	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—ITPR1—asthma	6.43e-05	0.00038	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCR5—asthma	6.42e-05	0.00038	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CSF2—asthma	6.38e-05	0.000377	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CXCL10—asthma	6.35e-05	0.000376	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—IL2RA—asthma	6.33e-05	0.000375	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCR3—asthma	6.29e-05	0.000372	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—C3—asthma	6.27e-05	0.000371	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCR4—asthma	6.25e-05	0.00037	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—ADRB2—asthma	6.17e-05	0.000365	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—STAT6—asthma	6.13e-05	0.000363	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NPY—asthma	6.13e-05	0.000363	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—EDN1—asthma	6.07e-05	0.000359	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCL5—asthma	6.02e-05	0.000357	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL2RB—asthma	6.01e-05	0.000356	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PDE4D—asthma	5.96e-05	0.000353	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PPP2CA—asthma	5.94e-05	0.000351	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CSF2—asthma	5.93e-05	0.000351	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—AGTR2—asthma	5.91e-05	0.00035	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—ITPR1—asthma	5.83e-05	0.000345	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCR5—asthma	5.83e-05	0.000345	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—C5—asthma	5.81e-05	0.000344	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PDE4B—asthma	5.81e-05	0.000344	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TACR1—asthma	5.81e-05	0.000344	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CXCL8—asthma	5.81e-05	0.000344	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—LTA4H—asthma	5.75e-05	0.00034	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL2RA—asthma	5.75e-05	0.00034	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—C3—asthma	5.7e-05	0.000337	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—EDNRB—asthma	5.66e-05	0.000335	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TAC1—asthma	5.6e-05	0.000332	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NPS—asthma	5.6e-05	0.000332	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—EDN1—asthma	5.51e-05	0.000326	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CXCR3—asthma	5.49e-05	0.000325	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCL5—asthma	5.47e-05	0.000324	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PLA2G4A—asthma	5.45e-05	0.000323	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCR5—asthma	5.43e-05	0.000321	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CSF2—asthma	5.39e-05	0.000319	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—IL2RA—asthma	5.35e-05	0.000317	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CYBA—asthma	5.32e-05	0.000315	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCR3—asthma	5.31e-05	0.000314	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—C3—asthma	5.3e-05	0.000314	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL5—asthma	5.21e-05	0.000308	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PARP1—asthma	5.21e-05	0.000308	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NPY—asthma	5.18e-05	0.000306	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ARG1—asthma	5.03e-05	0.000298	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—BDKRB2—asthma	5.03e-05	0.000297	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PPP2CA—asthma	5.02e-05	0.000297	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—POMC—asthma	5.02e-05	0.000297	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—AGTR2—asthma	5e-05	0.000296	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCR5—asthma	4.93e-05	0.000292	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ADCY2—asthma	4.86e-05	0.000288	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL2RA—asthma	4.86e-05	0.000287	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL3—asthma	4.85e-05	0.000287	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—C3—asthma	4.82e-05	0.000285	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—EDNRB—asthma	4.78e-05	0.000283	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NPS—asthma	4.74e-05	0.00028	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TAC1—asthma	4.74e-05	0.00028	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CXCR3—asthma	4.64e-05	0.000275	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—KNG1—asthma	4.57e-05	0.000271	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—POMC—asthma	4.56e-05	0.00027	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALDH7A1—asthma	4.55e-05	0.000269	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—AGTR1—asthma	4.55e-05	0.000269	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CYBA—asthma	4.5e-05	0.000266	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCL2—asthma	4.46e-05	0.000264	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL6R—asthma	4.45e-05	0.000263	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CXCL10—asthma	4.44e-05	0.000263	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—RHOA—asthma	4.42e-05	0.000262	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PARP1—asthma	4.4e-05	0.000261	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL5—asthma	4.4e-05	0.000261	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ARG2—asthma	4.36e-05	0.000258	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NTRK1—asthma	4.36e-05	0.000258	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ADRB2—asthma	4.31e-05	0.000255	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—BDKRB2—asthma	4.25e-05	0.000251	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—POMC—asthma	4.24e-05	0.000251	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ADCY2—asthma	4.11e-05	0.000243	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL3—asthma	4.1e-05	0.000242	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ITPR1—asthma	4.08e-05	0.000241	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—RHOA—asthma	4.02e-05	0.000238	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CD86—asthma	3.88e-05	0.00023	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CXCL8—asthma	3.88e-05	0.00023	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—KNG1—asthma	3.86e-05	0.000229	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—EDN1—asthma	3.85e-05	0.000228	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—POMC—asthma	3.85e-05	0.000228	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—AGTR1—asthma	3.84e-05	0.000227	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCL5—asthma	3.82e-05	0.000226	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PLA2G4A—asthma	3.81e-05	0.000225	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCL2—asthma	3.77e-05	0.000223	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CSF2—asthma	3.77e-05	0.000223	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL6R—asthma	3.76e-05	0.000222	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CXCL10—asthma	3.75e-05	0.000222	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—RHOA—asthma	3.74e-05	0.000221	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—IL2—asthma	3.71e-05	0.00022	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NTRK1—asthma	3.68e-05	0.000218	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SMAD3—asthma	3.67e-05	0.000217	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ADRB2—asthma	3.64e-05	0.000216	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALOX5AP—asthma	3.61e-05	0.000214	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALOX15—asthma	3.61e-05	0.000214	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CXCL8—asthma	3.53e-05	0.000209	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PPP2CA—asthma	3.51e-05	0.000208	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ITPR1—asthma	3.45e-05	0.000204	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CHAT—asthma	3.45e-05	0.000204	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCR5—asthma	3.44e-05	0.000204	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL2RA—asthma	3.39e-05	0.000201	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—RHOA—asthma	3.39e-05	0.000201	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL2—asthma	3.37e-05	0.000199	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—C3—asthma	3.37e-05	0.000199	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CD86—asthma	3.28e-05	0.000194	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CXCL8—asthma	3.28e-05	0.000194	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PDGFB—asthma	3.28e-05	0.000194	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—EDN1—asthma	3.26e-05	0.000193	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL5—asthma	3.23e-05	0.000191	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PLA2G4A—asthma	3.22e-05	0.000191	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CSF2—asthma	3.18e-05	0.000188	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—IL2—asthma	3.14e-05	0.000186	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—LEP—asthma	3.13e-05	0.000185	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SMAD3—asthma	3.1e-05	0.000183	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALOX5—asthma	3.07e-05	0.000182	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CXCL8—asthma	2.98e-05	0.000176	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PPP2CA—asthma	2.96e-05	0.000175	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—FN1—asthma	2.96e-05	0.000175	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CARM1—asthma	2.93e-05	0.000173	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCR5—asthma	2.91e-05	0.000172	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—DCN—asthma	2.89e-05	0.000171	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL2RA—asthma	2.87e-05	0.00017	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL2—asthma	2.85e-05	0.000169	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—C3—asthma	2.84e-05	0.000168	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALDH2—asthma	2.81e-05	0.000166	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PDGFB—asthma	2.77e-05	0.000164	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—POMC—asthma	2.69e-05	0.000159	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GSTT1—asthma	2.67e-05	0.000158	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—LEP—asthma	2.65e-05	0.000157	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCL2—asthma	2.63e-05	0.000156	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL6R—asthma	2.63e-05	0.000155	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—EGFR—asthma	2.58e-05	0.000153	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—FN1—asthma	2.5e-05	0.000148	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SERPINE1—asthma	2.46e-05	0.000146	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—RHOA—asthma	2.37e-05	0.00014	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NOS3—asthma	2.35e-05	0.000139	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—POMC—asthma	2.28e-05	0.000135	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL2—asthma	2.23e-05	0.000132	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—NQO1—asthma	2.22e-05	0.000131	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL6R—asthma	2.22e-05	0.000131	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—EGFR—asthma	2.18e-05	0.000129	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ADCY2—asthma	2.17e-05	0.000129	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CXCL8—asthma	2.08e-05	0.000123	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SERPINE1—asthma	2.08e-05	0.000123	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—RHOA—asthma	2e-05	0.000119	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL2—asthma	1.99e-05	0.000118	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NOS3—asthma	1.98e-05	0.000117	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL6—asthma	1.98e-05	0.000117	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MMP9—asthma	1.88e-05	0.000111	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PTEN—asthma	1.87e-05	0.000111	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GSTP1—asthma	1.85e-05	0.00011	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HMOX1—asthma	1.83e-05	0.000108	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ITPR1—asthma	1.82e-05	0.000108	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CAT—asthma	1.8e-05	0.000107	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CXCL8—asthma	1.76e-05	0.000104	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PLA2G4A—asthma	1.7e-05	0.000101	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GSTM1—asthma	1.7e-05	0.000101	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—VEGFA—asthma	1.69e-05	0.0001	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL2—asthma	1.68e-05	9.96e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—STAT3—asthma	1.67e-05	9.91e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL6—asthma	1.67e-05	9.91e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MMP9—asthma	1.59e-05	9.42e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PTEN—asthma	1.58e-05	9.37e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PPP2CA—asthma	1.57e-05	9.28e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TGFB1—asthma	1.55e-05	9.19e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—EGFR—asthma	1.52e-05	9.01e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—VEGFA—asthma	1.43e-05	8.46e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—STAT3—asthma	1.42e-05	8.38e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TGFB1—asthma	1.31e-05	7.77e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—EGFR—asthma	1.29e-05	7.61e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—POMC—asthma	1.2e-05	7.12e-05	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL6—asthma	1.17e-05	6.92e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALB—asthma	1.1e-05	6.49e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—NOS3—asthma	1.05e-05	6.21e-05	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL6—asthma	9.89e-06	5.85e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PTGS2—asthma	9.59e-06	5.68e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PTEN—asthma	8.37e-06	4.95e-05	CbGpPWpGaD
